Showing results (881-890 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 21, 2004
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseasesJasper M Bos, Philippe Beutels, Lieven Annemans, et al.Pharmacoeconomics|December 21, 2004
Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinomaAdele Weston, Patrick FitzgeraldPharmacoeconomics|December 21, 2004
The economic implications of non-adherence after renal transplantationIrina Cleemput, Katrien Kesteloot, Yves Vanrenterghem, et al.Pharmacoeconomics|May 18, 2005
Effects of antidepressants on quality of life in women with premenstrual dysphoric disorderEllen W FreemanPharmacoeconomics|May 18, 2005
Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?Adam La CazePharmacoeconomics|August 16, 2005
Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisitedElizabeth A Calhoun, Glen T Schumock, June M McKoy, et al.Pharmacoeconomics|August 16, 2005
Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiformeJanne A Martikainen, Akseli Kivioja, Taru Hallinen, et al.Pharmacoeconomics|August 16, 2005
Cost of illness and its predictors for Parkinson's disease in GermanyAnnika E Spottke, Martin Reuter, Olaf Machat, et al.Pharmacoeconomics|August 11, 2006
Cost effectiveness of leukotriene modifiers in adults with asthmaPamela C HeatonPharmacoeconomics|December 1, 2007
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?Denis Getsios, Kristen Migliaccio-Walle, Jaime J CaroPageof 336